Edition:
India

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

3.12USD
18 Apr 2019
Change (% chg)

$0.01 (+0.32%)
Prev Close
$3.11
Open
$3.18
Day's High
$3.18
Day's Low
$3.07
Volume
21,586
Avg. Vol
325,169
52-wk High
$9.19
52-wk Low
$1.56

About

Akari Therapeutics, Plc, formerly Celsus Therapeutics Plc, is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of treatments for a range of rare and orphan autoimmune and inflammatory diseases caused by dysregulation of complement component 5 (C5), including paroxysmal nocturnal... (more)

Overall

Beta: -3.83
Market Cap(Mil.): $49.32
Shares Outstanding(Mil.): 0.16
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates